Hindustan Bio Sciences files FY26 compliance report
Hindustan Bio Sciences Limited filed its Annual Secretarial Compliance Report for FY26, confirming full compliance with SEBI LODR regulations. The report, dated May 16, 2026, noted no deviations or non-compliances across statutory provisions, including insider trading and related party transactions.
*this image is generated using AI for illustrative purposes only.
Hindustan Bio Sciences Limited has filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, with the stock exchanges. The report, dated May 16, 2026, was issued by Mr. V B S S Prasad, a Practicing Company Secretary, following a review of the company's adherence to statutory provisions and good corporate practices.
Compliance Overview
The review confirmed that hindustan bio sciences complied with the provisions of the SEBI (LODR) Regulations, 2015, and other applicable guidelines during the review period. The examination included the company's books, papers, minutes books, forms, returns, and other records. The report also verified compliance with the Securities Contracts (Regulation) Act, 1956, and the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Key Findings
The report detailed the compliance status across various regulatory requirements. It noted that the company has adopted and updated all applicable policies under SEBI regulations with board approval. Furthermore, the company maintains a functional website with timely dissemination of required documents.
| Compliance Requirement | Status | Remarks |
|---|---|---|
| Secretarial Standards | Yes | None |
| Adoption of Policies | Yes | None |
| Website Disclosures | Yes | None |
| Director Disqualification | Yes | None |
| Preservation of Documents | Yes | None |
| Performance Evaluation | Yes | None |
| Related Party Transactions | Yes | None |
| Event Disclosures | Yes | None |
| Insider Trading | Yes | None |
Additional Disclosures
The report stated that the company does not have any subsidiary companies during the period under review. It also confirmed that no actions were taken against the listed entity, its promoters, or directors by SEBI or the Stock Exchanges. M/s. VASG & ASSOCIATES, Chartered Accountant, continued as the statutory auditor for the term ending 2026-27, with no resignation occurring during the financial year.
Historical Stock Returns for Hindustan Bio Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.86% | -4.79% | -6.91% | +31.38% | +3.67% | +112.38% |
Will Hindustan Bio Sciences Limited pursue any subsidiary acquisitions or joint ventures in the biosciences sector to expand its operational footprint beyond its current standalone structure?
How might Hindustan Bio Sciences' consistent regulatory compliance record influence its ability to attract institutional investors or secure future funding rounds?
Given the company's clean compliance slate, are there any planned expansions or new product launches in the pipeline that could drive revenue growth in FY2026-27?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
